HHS cuts 7 drugs from Medicare Part B rebates list

(By Rylee Wilson for Becker’s Hospital Review)

HHS has removed seven drugs from its initial list of 27 drugs subject to inflation rebates.

As part of the Inflation Reduction Act, the federal government can levy fines against drug manufacturers who raise the cost of drugs covered by Medicare Part B higher than the rate of inflation. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org